HotSpot Therapeutics
Small molecule drugs that modulate protein allostery and cellular regulation for therapeutic effect
- Sector
- Biotech
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 40 pending
Capital timeline
No federal awards or Form D filings are on record for this company.
Many early companies raise without filing a Form D, or have not yet won a federal award. New records appear here as the sources update.
Checked: SEC EDGAR Form D through Oct 23, 2026; SBIR and STTR awards through Oct 21, 2026; USAspending contract awards
Founder? Add funding contextFounders and team
No founders are linked to this company yet.
Founders appear once a person is matched to the company through its own patents, grants or filings. We never infer people from social profiles.
Checked: USPTO inventors; federal award principal investigators; SEC Form D related persons · Oct 23, 2026
Claim this profile to add your teamWhat it has protected
USPTO · 0 granted of 40- PendingIsothiazolylcarboxamide Compounds And Their Use In TherapyUSPTOApplication 19110203
- PendingCompounds, Compositions And Methods Of Treating DisordersUSPTOApplication 19172091
- PendingPyrazolylcarboxamide Compounds And Their Use In TherapyUSPTOApplication 19110200
Show all 40 patent records
- Isothiazolylcarboxamide Compounds And Their Use In TherapyMay 7, 2026 · Application 19110203Pending
- Compounds, Compositions And Methods Of Treating DisordersApr 23, 2026 · Application 19172091Pending
- Pyrazolylcarboxamide Compounds And Their Use In TherapyMar 26, 2026 · Application 19110200Pending
- Heterocyclic Cbl-b Inhibitors For The Treatment Of CancerMar 26, 2026 · Application 19171907Pending
- Cbl-b Inhibitors And ANTI-PD1/ANTI-PD-L1 For Use In The Treatment Of CancerDec 11, 2025 · Application 19016686Pending
- Compounds, Compositions And Methods Of Treating DisordersNov 6, 2025 · Application 19172052Pending
- Cbl-b Inhibitor, Compositions Comprising A Cbl-b Inhibitor In A Method Of Treating A Disease Associated With Cell ProliferationMay 22, 2025 · Application 19016632Pending
- Treatment Of Cell Proliferation-associated Conditions Using A Combination Of A Clb-b Inhibitor And An Additional Therapeutic AgentMay 15, 2025 · Application 19016716Pending
- Methods Of Preparation Of Heterocyclic CompoundsMay 8, 2025 · Application 19016575Pending
- Solid Forms Of A Triazine Derivative As Cbl-b ModulatorMay 8, 2025 · Application 19016543Pending
- Compounds, Compositions And Methods Of Treating CancerJul 11, 2024 · Application 18286966Pending
- Pyridinylsulfonamide Compounds And Their Use In TherapyMay 9, 2024 · Application 18237989Pending
- Pyrazolylsulfonamide Compounds And Their Use In TherapyMay 9, 2024 · Application 18455767Pending
- Biomarkers Of Cbl-b InhibitionApplication 63662552Pending
- Indazolyl-piperidine Sulfonamides And Related Compounds And Their Use In TherapyApplication 63605105Pending
- Compounds, Compositions And Methods Of Treating DisordersApplication PCTUS2023077322Pending
- Compounds, Compositions And Methods Of Treating DisordersApplication PCTUS2023076248Pending
- Compounds, Compositions And Methods Of Treating DisordersApplication PCTUS2023076236Pending
- Pyrazolylcarboxamide Compounds And Their Use In TherapyApplication PCTUS2023073908Pending
- Isothiazolylcarboxamide Compounds And Their Use In TherapyApplication PCTUS2023073971Pending
- Pyridinylsulfonamide Compounds And Their Use In TherapyApplication PCTUS2023031115Pending
- Pyrazolylsulfonamide Compounds And Their Use In TherapyApplication PCTUS2023072880Pending
- Compounds, Compositions And Methods Of Treatment ThereofApplication PCTUS2023070042Pending
- Solid Forms And Methods Of UseApplication PCTUS2023070010Pending
- Methods Of Preparation Of Heterocyclic CompoundsApplication PCTUS2023070059Pending
- Compounds, Compositions And Methods Of Treatment ThereofApplication PCTUS2023070062Pending
- Compounds, Compositions And Methods Of Treatment ThereofApplication PCTUS2023070061Pending
- Compounds, Compositions And Methods Of Treating DisordersApplication 63417366Pending
- Compounds, Compositions And Methods Of Treating DisordersApplication 63414343Pending
- Compounds, Compositions And Methods Of Treating DisordersApplication 63414257Pending
- Isothiazolylcarboxamide Compounds And Their Use In TherapyApplication 63405676Pending
- Pyrazolylcarboxamide Compounds And Their Use In TherapyApplication 63405668Pending
- Pyridinylsulfonamide Compounds And Their Use In TherapyApplication 63401491Pending
- Pyrazolylsulfonamide Compounds And Their Use In TherapyApplication 63401490Pending
- Solid Forms And Methods Of UseApplication 63388342Pending
- Compounds, Compositions And Methods Of Treatment ThereofApplication 63388518Pending
- Compounds, Compositions And Methods Of Treatment ThereofApplication 63388506Pending
- Compounds, Compositions And Methods Of Treatment ThereofApplication 63388480Pending
- Methods Of Preparation Of Heterocyclic CompoundsApplication 63388344Pending
- Compounds, Compositions And Methods Of Treating DisordersApplication PCTUS2022025083Pending
Related companies, and why
- NEOKERA, LLCSimilar federal contract value in Biotech · null in contracts
- CARDIOCREATE, INC.Similar federal contract value in Biotech · null in contracts
- NEONEURON, LLCSimilar federal contract value in Biotech · null in contracts
- INNOVIMMUNE BIOTHERAPEUTICS HOLDING, LLCSimilar federal contract value in Biotech · null in contracts
- Lenz Therapeutics, Inc.Similar federal contract value in Biotech · null in contracts
- COMPUTCHEM LLCSimilar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .